Blueprint Medicines Corp (BPMC) insider trading

Every open-market stock purchase and sale by Blueprint Medicines Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

No open-market insider trades in the last 12 months.
Last insider buy: Kate Haviland (CEO), $48.4K, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $129.46 on Jul 16, 2025.

Recent BPMC insider trades

No open-market trades in the last 12 months.

Get free alerts when an insider at Blueprint Medicines Corp files a new trade →